{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "6878868", "DateCompleted": {"Year": "1983", "Month": "09", "Day": "23"}, "DateRevised": {"Year": "2015", "Month": "11", "Day": "19"}, "Article": {"Language": ["eng"], "ELocationID": [], "ArticleDate": [], "Journal": {"ISSN": "0034-5164", "JournalIssue": {"Volume": "40", "Issue": "2", "PubDate": {"Year": "1983", "Month": "May"}}, "Title": "Research communications in chemical pathology and pharmacology", "ISOAbbreviation": "Res Commun Chem Pathol Pharmacol"}, "ArticleTitle": "Interactions of ozone and antineoplastic drugs on rat lung fibroblasts and Walker rat carcinoma cells.", "Pagination": {"StartPage": "279", "EndPage": "287", "MedlinePgn": "279-87"}, "Abstract": {"AbstractText": ["Cultured rat lung fibroblasts (F-cells) and Walker rat carcinoma cells (WRC-cells) labeled with 51Cr were exposed to the following antitumor drugs alone or with O3: carmustine (BCNU), doxorubicin (Dox), cisplatin (CPt), mitomycin C (Mit C) or vitamin K3 (Vit K). Release of 51Cr (cell injury) was greater for F-cells than WRC-cells with any single treatment. Pretreatment with any drug (400 microM), except for Vit K with WRC-cells, did not significantly increase O3-induced loss of 51Cr. Co-exposure of F-cells to drugs and O3 resulted in a marked potentiation of O3-induced injury with Vit K, and an inhibition with Dox."]}, "AuthorList": [{"AffiliationInfo": [], "Identifier": [], "LastName": "Wenzel", "ForeName": "D G", "Initials": "DG"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Morgan", "ForeName": "D L", "Initials": "DL"}], "GrantList": [{"GrantID": "ES01315", "Acronym": "ES", "Agency": "NIEHS NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't", "Research Support, U.S. Gov't, Non-P.H.S.", "Research Support, U.S. Gov't, P.H.S."]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Res Commun Chem Pathol Pharmacol", "NlmUniqueID": "0244734", "ISSNLinking": "0034-5164"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Chromium Radioisotopes"}, {"RegistryNumber": "12001-79-5", "NameOfSubstance": "Vitamin K"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["toxicity"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Carcinoma 256, Walker"}, {"QualifierName": [], "DescriptorName": "Cells, Cultured"}, {"QualifierName": [], "DescriptorName": "Chromium Radioisotopes"}, {"QualifierName": ["drug effects"], "DescriptorName": "Fibroblasts"}, {"QualifierName": ["toxicity"], "DescriptorName": "Ozone"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Vitamin K"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1983", "Month": "5", "Day": "1"}, {"Year": "1983", "Month": "5", "Day": "1", "Hour": "0", "Minute": "1"}, {"Year": "1983", "Month": "5", "Day": "1", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["6878868"]}}], "PubmedBookArticle": []}